This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Multiple sclerosis qualifies one for getting access to medical cannabis in some states in the US. In 2005, a group of researchers was looking into the effectiveness and long-term safety of tetrahydrocannabinol for MS. However, not all patients respond to these treatments well enough, and some don’t respond at all.
Protecting youth – particularly young people of color, who continue to be disproportionately impacted – by both eliminating a common reason for introduction to the criminal justice system and preventing access to marijuana through a regulated market.
Our primary objective is to be the platform that embodies safety in cannabis through innovative solutions, method development, integrity in reporting, and through advocacy for sensible regulations on behalf of the industry and consumers.”. Inevitably, this drives product development and greater value for brands and consumers.”. About SC Labs.
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.
The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer. Rick Doblin, Ph.D., Members of the U.S.
Department of Cannabis Control (Accela Citizen Access). Los Angeles Open Data. Published Via The Mondaq Platform. 20 November 2021. by Joe Rogoway. Rogoway Law. Cannabis Compliance Team, Rogoway Law Group. San Francisco, CA; Retrieved from: [link]. State of California. License Search. State of California. 1,027 Acres. publication).
ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.
times higher than the arrest rate for white individuals from 2010-2019, and their conviction rate was 3.9 Statewide polling data released Feb. The study and the workgroup both prioritized legalization that ensures equity, consumer safety and restorative justice. times higher than white individuals. View original article.
On June 23, Canada’s cannabis regulatory agency, Health Canada, released a private document requested under the Access to Information Act (AIA), that country’s version of the US government’s Freedom of Information Act. The document in question was a 2020 safety study of the vape cartridge additive phytol. Its contents floored him.
was published in the Journal of Safety Research and made available online on May 18. Journal of Safety Research. The objective of the current study was to assess the ease of access to marijuana by underage patrons at recreational marijuana outlets in California, where recreational marijuana was legalized in 2016.
Multivariate analysis of overall survival and nonrelapse mortality (NRM) data has shown GVHD likelihood can be impacted by age, prior acute GVHD, time from transplantation to cGVHD, donor type, disease status at transplantation, GVHD prophylaxis, gender mismatch, serum bilirubin, Karnofsky score, and platelet count (Arora et al. Implications.
Billion to Enforce the Drug War (2010-2019). People who have access to harm reduction programs are five times more likely to connect with drug treatment than those who do not and three times more likely to stop problematic drug use. times greater than it had been in 2010; for Black residents, this rate was 3.6 billion annually.
This continues to create challenges for marijuana businesses, including access to the payment and banking systems. 2010, May 28). xiii Dispensary counts are estimated using current business licensing data from Colorado Department of Revenue Enforcement Division. The data can be found here: [link]. Conclusion.
Track-and-Trace System Reporting Requirements, Section 40513 Track-and-Trace – Loss of Access, Section 40515 Track-and-Trace Temporary Licenses, and Section 40517 Track-and-Trace System – UID Tag Order. All electronic storage systems must provide a complete and accurate record of your data that is accessible to the IRS. .
He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. Through its discovery platform, Delix has identified a class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Matthew Johnson. Ingmar Gorman.
I) the provision of a telecommunications service, or of an Internet access service or Internet information location tool (as those terms are defined in section 231 of title 47 ); or. . (II) 3, 2010 , 124 Stat. Preventing marijuana possession or use on federal property. . 109–248, title II , § ? 201, July 27, 2006 , 120 Stat.
Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018. Many of these are meant to address public safety risks, especially for young people. billion in 2018, and with a compound annual growth rate of 23.9%, is predicted to reach $66.3
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content